Understanding clinical meaningfulness when targeting the depressor anguli oris muscle (DAO) with neuromodulators: a clinical prospective interventional study

2024-9-14

Autonomic regulation and comorbid symptoms in children with attention deficit hyperactivity disorder

2024-9-11

Dopamine agonists in the treatment of Parkinson's disease: the show must go on

2024-9-11

An efficient ranking-based ensembled multiclassifier for neurodegenerative diseases classification using deep learning

2024-9-9

The relationship between sphingomyelin and ceramide levels and soft neurological signs in ADHD

2024-9-9

Behavioral disorders in dementia with Lewy bodies: old and new knowledge

2024-9-6

Unraveling the mechanisms of high-level gait control in functional gait disorders

2024-9-6

Behavioral disorders in multiple sclerosis: a comprehensive review

2024-9-4

Therapeutic drug monitoring in Parkinson’s disease

2024-9-3

The role of fatigue in attentional processing in multiple sclerosis: data from event-related potentials

2024-8-28

Eyes as a window to brain pathology in parkinson’s disease: a narrative review

2024-8-24

Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes

2024-8-23

Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease

2024-8-19

The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states

2024-8-17

Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016

2024-8-13

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

2024-8-9

Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction

2024-8-7

Acceptance of psychosocial bridging measures in context of dementia

2024-8-7

Timing and cortical region matter: theta power differences between teenagers affected by Major Depression and healthy controls

2024-8-6

Neuroplasticity in Parkinson’s disease

2024-8-5

Quantitative EEG in Parkinson’s disease: when REM sleep behavior disorder onset really matters

2024-7-25

Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson’s disease

2024-7-25

Therapy with botulinum neurotoxin for Parkinson’s disease

2024-7-25

Tips and tricks in tremor treatment

2024-7-24

Multidisciplinary care in Parkinson’s disease

2024-7-23

The relationship between uric acid levels, cognition and inflammation in a cohort of elderly subjects

2024-7-18

The neural structures of theory of mind are valence-sensitive: evidence from three tDCS studies

2024-7-17

Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies

2024-7-15

Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders

2024-7-15

Cognition and Activity of Daily Living Function in people with Parkinson’s disease

2024-7-8

Sex-dependent associations of serum BDNF, glycolipid metabolism and cognitive impairments in Parkinson’s disease with depression: a comprehensive analysis

2024-7-5

Monotherapy with infusion therapies – useful or not?

2024-7-5

The why and how of the SynNerGe criteria of Parkinson´s disease

2024-6-25

Differential diagnosis of Huntington’s disease− neurological aspects of NKX2-1-related disorders

2024-6-25

Anticholinergic drugs for parkinsonism and other movement disorders

2024-6-21

From parents to children: associations of traffic risks with impulsivity, family relationships and serotonin transporter genotype

2024-6-20

Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study

2024-6-19

In situ stoichiometry amounts of p62 and poly-ubiquitin exceed the increase of alpha-synuclein during degeneration of catecholamine cells induced by autophagy inhibition in vitro

2024-6-18

Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice

2024-6-14

Pathomechanisms of behavioral abnormalities in Huntington disease: an update

2024-6-14

Depression and anxiety in multiple sclerosis. Review of a fatal combination

2024-6-13

Clinical and diagnostic features of long-COVID patients presenting with neurologic symptoms in Chicago

2024-6-7

Does botulinum toxin affect psycho-social aspects in dystonia?

2024-6-4

Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson’s disease: a 1-year observational study

2024-6-1

Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future

2024-6-1

Possible improvement of social adjustment after subthalamic deep brain stimulation in people with Parkinson’s disease? A systematic review and meta-analysis

2024-5-25

Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms

2024-5-18

What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience

2024-5-15

Clinical and kinematic characterization of parkinsonian soft signs in essential tremor

2024-5-14

Sublingual apomorphine in the treatment of Parkinson’s disease

2024-5-14